• Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Trabi Share Price

    Transgene Biotek Share PriceTransgene Biotek

    Small Cap 1.9k Result
    ₹8.64
    -0.45 (-4.95%)
    As on 28 November, 2023 | 21:32 BSE: 526139 NSE: TRABIISIN: INE773D01018

    Transgene Biotek Performance

    Day Range

    • Low
    • High
    8.64

    52 Week Range

    • Low
    • High
    8.64
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Transgene Biotek

    Start SIP

    Transgene Biotek Share Price

    • Over 1 Month 110.73%
    • Over 3 Month 95.03%
    • Over 6 Month 117.63%
    • Over 1 Year 198.96%

    Transgene Biotek Key Statistics

    Transgene Biotek Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 0000000
    Operating Expenses Qtr Cr 0000100
    Operating Profit Qtr Cr 0000-100
    Depreciation Qtr Cr 0011113
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 00-1-1-2-1-3
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 00
    Operating Expenses Annual Cr 11
    Operating Profit Annual in Cr -10
    Depreciation Cr 510
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr -6-10
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 0
    Cash from Investing Activity Annual Cr 0
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr -60
    Fixed Assets Annual Cr 813
    Total Non Current Assets Annual Cr 3237
    Total Current Assets Annual Cr 11
    Total Assets Annual Cr 3237
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs -10
    ROE Annual % 00
    ROCE Annual % -26-36
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -1,592-289
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 0000000
    Operating Expenses Qtr Cr 0000100
    Operating Profit Qtr Cr 0000-100
    Depreciation Qtr Cr 0011113
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 00-1-1-2-1-3
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 00
    Operating Expenses Annual Cr 11
    Operating Profit Annual in Cr -10
    Depreciation Cr 510
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr -6-10
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 0
    Cash from Investing Activity Annual Cr 0
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1117
    Fixed Assets Annual Cr 813
    Total Non Current Assets Annual Cr 141146
    Total Current Assets Annual Cr 11
    Total Assets Annual Cr 142147
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 22
    ROE Annual % -53-60
    ROCE Annual % -4-7
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -1,592-290
    Invest in Transgene Biotek

    Transgene Biotek Technicals

    EMA & SMA

    Current Price
    ₹8.64
    -0.45 (-4.95%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹6.75
    • 50 Day
    • ₹5.5
    • 100 Day
    • ₹4.8
    • 200 Day
    • ₹4.22
    • 20 Day
    • ₹6.26
    • 50 Day
    • ₹4.97
    • 100 Day
    • ₹4.53
    • 200 Day
    • ₹3.85

    Transgene Biotek Resistance and Support

    PIVOT
    ₹8.93
    Resistance
    First Resistance ₹9.22
    Second Resistance ₹9.79
    Third Resistance ₹10.08
    RSI 84.95
    MFI 91.19
    MACD Single Line 0.87
    MACD 1.15
    Support
    First Resistance ₹8.36
    Second Resistance ₹8.07
    Third Resistance ₹7.5

    Transgene Biotek Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 354,410 35,441,000 100
    Week 927,552 92,755,200 100
    1 Month 236,876 23,687,610 100
    6 Month 86,076 8,607,646 100

    Transgene Biotek Result Highlights

    Transgene Biotek Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Transgene Biotek Corporate Action

    Date Purpose Remarks
    2023-11-14 Quarterly Results & Others
    2023-08-05 Quarterly Results & Others
    2023-05-30 Audited Results
    2023-02-14 Quarterly Results
    2022-11-12 Quarterly Results

    Transgene Biotek FAQs

    What is Share Price of Transgene Biotek ?

    Transgene Biotek share price is ₹8 As on 28 November, 2023 | 21:18

    What is the Market Cap of Transgene Biotek ?

    The Market Cap of Transgene Biotek is ₹65.5 Cr As on 28 November, 2023 | 21:18

    What is the P/E ratio of Transgene Biotek ?

    The P/E ratio of Transgene Biotek is -21 As on 28 November, 2023 | 21:18

    What is the PB ratio of Transgene Biotek ?

    The PB ratio of Transgene Biotek is 5.8 As on 28 November, 2023 | 21:18

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.